Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 21 (KLHL21) is a member of the Kelch-like protein family that functions primarily as a substrate-specific adapter for the Cullin 3-based E3 ubiquitin-protein ligase complex, contributing to protein ubiquitination and the regulation of chromosome passenger complex localization at the spindle midzone during mitosis[3][1]. KLHL21 is essential for cytokinesis and correct cell division, as well as negatively regulating the activation of IκB kinase-β (IKKβ), thereby modulating NF-κB signaling[1]. Dysregulated expression of KLHL21 promotes cancer cell proliferation, migration, and invasion, particularly in hepatocellular carcinoma, where it may serve as a prognostic biomarker and potential therapeutic target[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 21 (KLHL21).